Figure 1: Rapid CO 2-induced release of ATP from the ventral surface of the medulla. Figure 3: ATP receptor blockade on the chemosensitive areas of the ventral medullary surface attenuates the effect ...
(RTTNews) - Boston Scientific Corp. (BSX) announced positive six-month results from the ongoing pivotal MODULAR ATP clinical trial of the mCRM System, the first modular cardiac rhythm management ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback